BioHealth News Archive
BHI Entrepreneur-in-Residence Feedback Session – March 20th
Are you a start-up in Maryland, DC or Virginia seeking feedback on your biohealth business idea, pitch deck, or commercialization plan? Sign up by…
Read More
Strong interest in Non-Dilutive Funding Programs
More than 120 people registered for last week’s SBIR Workshop organized by BioHealth Innovation in partnership with Launch Workplaces and support from TEDCO and…
Read More
State Department awards Emergent BioSolutions contract for chemical warfare countermeasures – Homeland Preparedness News
Emergent BioSolutions announced today that the company has signed a deal with the U.S. Department of State to establish a supply chain for certain…
Read More
NEA is raising its biggest fund ever – – again – TechCrunch
New Enterprise Associates, the 41-year-old venture firm with offices in Menlo Park; San Francisco; Boston; New York; Chevy Chase, Md.; and Washington, D.C., is…
Read More
Alexandria RE Equities Launches ‘GradLabs’ Product in San Diego | GlobeSt
Office REIT Alexandria Real Estate Equities reports it has launched a new product geared to providing post-seed-stage life science companies with turnkey, fully furnished…
Read More
MaxCyte Announces Multi-Drug Clinical & Commercial Agreement with Kite, a Gilead Company
MaxCyte, the global cell-based medicines and life sciences company, announced today that it has expanded its relationship with Kite, a Gilead Company, by entering…
Read More
A $100 Genome Within Reach, Illumina CEO Asks If World Is Ready
Francis deSouza Photographer: Jeff Spicer/PA Wire via AP For years, the cost to decode a full human genome has been falling much like computer…
Read More
Gilead’s Kite pens 10-target CAR-T tech deal with MaxCyte – FierceBiotech
Gilead’s Kite Pharma has expanded its CAR-T agreement with MaxCyte. The revised deal gives Kite the chance to apply MaxCyte’s transfection technology to up…
Read More
RFI Deadline Approaching: Understanding the Health of Women and the Role of Sex/Gender in Mechanisms of Heart, Lung, Blood, and Sleep Diseases and Disorders
The biomedical research community has made major progress in achieving a balance of men and women in human studies, however compelling questions about the…
Read More
Rexahn Pharmaceuticals Appoints Lara S. Sullivan to its Board of Directors :: Rexahn Pharmaceuticals, Inc. (RNN)
Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing innovative therapies to improve patient outcomes in cancers that are difficult to…
Read More
2018 was a record year for venture capital, but not for women founders – Washington Business Journal
The share of funding going to women-founded startups went down despite a massive influx of dollars to the region. {iframe}https://www.bizjournals.com/washington/news/2019/02/28/greater-washington-had-a-record-year-for-venture.html{/iframe}
Read More
Sanofi, Bayer and Roche execs underscore the value of digital therapeutics – MedCity News
Biopharma companies have long been looking for a way to go beyond the molecule/pill.The nascent but growing digital therapeutics industry set to grow to…
Read More
Pfizer: Countries free-riding on US innovation – BBC News
Albert Bourla told a US Senate hearing that other nations are "free-riding on American innovation". {iframe}https://www.bbc.com/news/business-47377427{/iframe}
Read More
Van Hollen: Despite Trump, NIH Significantly ‘Better Off’ In Terms of Funding
Funding for the Bethesda-based National Institutes of Health is up by 14 percent during the two years that President Donald Trump has been in…
Read More
BioBuzz with JHU MoCo – March 13th
When: Wednesday, March 13, 2019 from 5:00 PM to 7:00 PM Where: Bar Louie 150 Gibbs St Rockville, MD 20850 Join BioBuzz and Founding…
Read More